Literature DB >> 6283677

Recurring cystosarcoma phyllodes associated with breast carcinoma.

K Stone-Tolin, E W Pollak, W Dorzab, J Printz.   

Abstract

A 59-year-old patient, who had had recurring giant fibroadenomas and cystosarcoma phyllodes over a 36-year period, presented with cystosarcoma phyllodes and adenocarcinoma of the breast. Only seven other well documented instances of the coexistence of these lesions have been reported. The prognosis and treatment of adenocarcinoma was not affected by coexisting cystosarcoma phyllodes.

Entities:  

Mesh:

Year:  1982        PMID: 6283677     DOI: 10.1097/00007611-198207000-00033

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  The coexistence of lobular carcinoma in a fibroadenoma with a malignant phyllodes tumor in the opposite breast: report of a case.

Authors:  T Morimoto; T Tanaka; K Komaki; M Sasa; Y Monden; H Kumagai; H Otsuka
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

2.  Malignant phyllodes tumour with liposarcomatous differentiation, invasive tubular carcinoma, and ductal and lobular carcinoma in situ: case report and review of the literature.

Authors:  Mardiana Abdul Aziz; Frank Sullivan; Michael J Kerin; Grace Callagy
Journal:  Patholog Res Int       Date:  2010-07-05

Review 3.  Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival.

Authors:  H Vorherr; U F Vorherr; D M Kutvirt; C R Key
Journal:  Arch Gynecol       Date:  1985

4.  An 11 kg Phyllodes tumor of the breast in combination with other multiple chronic diseases: Case report and review of the literature.

Authors:  Zhilong Zhao; Jia Zhang; Yuanyuan Chen; Lanwan Shen; Jiansheng Wang
Journal:  Oncol Lett       Date:  2013-05-22       Impact factor: 2.967

5.  Huge Fungating Benign Phyllodes Tumor of Breast.

Authors:  Altaf Hussain Rathore
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.